Overview

Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura

Status:
Completed
Trial end date:
2018-08-11
Target enrollment:
Participant gender:
Summary
The study rationale is to provide evidence on effective doses of moxidectin and/or moxidectin-albendazole in adolescents (16-18 years old) infected with Trichuris trichiura. The study will take place on Pemba Island, Tanzania.
Phase:
Phase 2
Details
Lead Sponsor:
Swiss Tropical & Public Health Institute
Collaborator:
Public Health Laboratory Ivo de Carneri
Treatments:
Albendazole
Milbemycin
Moxidectin